Babu Subramanyam
Rapt Therapeutics (United States)(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Ferroelectric and Piezoelectric Materials, Hemophilia Treatment and Research, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Amino Acid Enzymes and Metabolism
Most-Cited Works
- → Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment(2010)229 cited
- → Identification and Characterization of a Potent, Selective, and Orally Active Antagonist of the CC Chemokine Receptor-1(2000)208 cited
- → Lipoxins and novel 15‐epi‐lipoxin analogs display potent anti‐inflammatory actions after oral administration(2004)137 cited
- → Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats(1990)130 cited
- → Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm in Apolipoprotein E–Deficient Mice by Inhibiting Apoptosis and Proteolysis(2005)129 cited
- → Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators(2005)97 cited
- → Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite(1991)92 cited
- → Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol(1991)81 cited
- → Novel 3-Oxa Lipoxin A4 Analogues with Enhanced Chemical and Metabolic Stability Have Anti-inflammatory Activity in Vivo(2004)78 cited
- → Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors(2007)67 cited